Design of clinical trials to assess diabetes treatment: Minimum duration of continuous glucose monitoring data to estimate time-in-ranges with the desired precision.

Camerlingo, Nunzio; Vettoretti, Martina; Sparacino, Giovanni; Facchinetti, Andrea; Mader, Julia K; Choudhary, Pratik; Del Favero, Simone

Camerlingo, Nunzio; Vettoretti, Martina; Sparacino, Giovanni; Facchinetti, Andrea; Mader, Julia K; Choudhary, Pratik; Del Favero, Simone.

Afiliação

Camerlingo N; Department of Information Engineering, University of Padova, Padova, Italy.
Vettoretti M; Department of Information Engineering, University of Padova, Padova, Italy.
Sparacino G; Department of Information Engineering, University of Padova, Padova, Italy.
Facchinetti A; Department of Information Engineering, University of Padova, Padova, Italy.
Mader JK; Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
Choudhary P; Department of Diabetes, School of Life Course Sciences, King's College London, London, UK.
Del Favero S; Department of Diabetes, Leicester Diabetes Centre, University of Leicester, Leicester, UK.

Diabetes Obes Metab ; 23(11): 2446-2454, 2021 11.

Article em En | MEDLINE | ID: mdl-34212483

Assuntos

Glicemia; Diabetes Mellitus Tipo 1; Automonitorização da Glicemia; Diabetes Mellitus Tipo 1/tratamento farmacológico; Humanos; Fatores de Tempo

Palavras-chave

clinical trial; continuous glucose monitoring; cost-effectiveness; type 1 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicemia / Diabetes Mellitus Tipo 1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google